METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
The current disclosure provides for novel multi-specific CAR molecules for the treatment of glioblastoma (also called GBM or glioblastoma multiforme). This disclosure also describes nucleic acids encoding for the polypeptides, expression vectors comprising the nucleic acids, cells and/or populations...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
12.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The current disclosure provides for novel multi-specific CAR molecules for the treatment of glioblastoma (also called GBM or glioblastoma multiforme). This disclosure also describes nucleic acids encoding for the polypeptides, expression vectors comprising the nucleic acids, cells and/or populations of cells expressing the polypeptides and/or comprising the nucleic acids or expression vectors of the disclosure, and compositions comprising the polypeptides, nucleic acids, or cells. |
---|---|
Bibliography: | Application Number: US202118042985 |